Summary
A French company has developed a post-processing software for cardiovascular MRI, 4D Flow and CT scan powered by artificial intelligence. In order to expand the brand, it wants to reinforce its presence worldwide via distributors. The company is seeking cardiology, medical imaging or AI companies with a strong position in different countries and close relationships with radiologists and cardiologists.
Description
The solution proposed by the French company is a post-processing software for cardiovascular MRI (magnetic resonance imaging), 4D Flow, and CT (computed tomography) scan based on artificial intelligence and deep-learning algorithms.
It is a class IIa medical device, CE marked since 2017, FDA (Food and Drug Administration) and TFDA (Taiwan Food and Drug Administration) cleared since 2022. Vendor-neutral, the solution is a diagnostic aid for the practitioner, that delivers an automated segmentation to quantify and qualify cardiac imaging information.
Its main objective is to produce fast and accurate analysis, letting physicians focus on patient care and wellness, by intuitively guiding its user through the modalities. Available in 7 languages, it is adapted to the international context in which it operates. Easy to use and compatible with an entry-level computer, it has been designed to meet the demands and needs of physicians to diagnose their patients' cardiovascular pathologies.
This diagnostic software integrates the main sequences for cardiovascular analysis : Cardiac Function and Strain, for cine sequences, Aortic Flow and compliance, delayed enhancement, First Pass and T1, T2, T2* mapping for tissue specification & quantification, with a full report at the end.
A solution for 4D flow analysis is also available, to complete the package.